 | • レポートコード：MRC2303I0218 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界の血管スクリーニング装置市場規模が、予測期間中に年平均5.5%で成長すると予測しています。本書では、血管スクリーニング装置の世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別（可動型、スタンドアロン型）分析、エンドユーザー別（病院、診断センター/診療所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、その他）分析、競争状況、市場機会・将来の動向など、以下の構成でまとめております。また、Collaborative Care Diagnostics LLC （Biomedix）、CorVascular Diagnostics, LLC、D.E. Hokanson Inc.、enverdis GmbH、Fukuda、Koven Technology Inc.、OMRON HEALTHCARE Co. Ltd、Shenzhen Mindray Bio-Medical Electronics Co. Ltdなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の血管スクリーニング装置市場規模：製品種類別 - 可動型血管スクリーニング装置の市場規模 - スタンドアロン型血管スクリーニング装置の市場規模 ・世界の血管スクリーニング装置市場規模：エンドユーザー別 - 病院における市場規模 - 診断センター/診療所における市場規模 - その他エンドユーザーにおける市場規模 ・世界の血管スクリーニング装置市場規模：地域別 - 北米の血管スクリーニング装置市場規模 アメリカの血管スクリーニング装置市場規模 カナダの血管スクリーニング装置市場規模 メキシコの血管スクリーニング装置市場規模 … - ヨーロッパの血管スクリーニング装置市場規模 ドイツの血管スクリーニング装置市場規模 イギリスの血管スクリーニング装置市場規模 フランスの血管スクリーニング装置市場規模 … - アジア太平洋の血管スクリーニング装置市場規模 中国の血管スクリーニング装置市場規模 インドの血管スクリーニング装置市場規模 日本の血管スクリーニング装置市場規模 … - その他地域の血管スクリーニング装置市場規模 ・競争状況 ・市場機会・将来の動向 |
The vascular screening devices market is expected to register a CAGR of 5.5% during the forecast period.
During the COVID-19 pandemic, it was known that the lung was the primary organ to be affected; however, recent research indicates that SARS-CoV-2 infection can result in vascular illness also. According to the study published in JACC: Cardiovascular Imaging Journal in September 2021, in the early stages of the pandemic, there was a considerable decrease in cardiovascular testing in the United States, with significant variation between locations.
Furthermore, numerous studies revealed that persons with heart illnesses were particularly vulnerable to COVID-19, which decreased patient traffic in hospitals and diagnostic centers. According to the study published by the National Center for Biotechnology Information (NCBI) in May 2021, during the COVID-19 pandemic, cardiac procedural activity in England decreased dramatically, with a deficit of approximately 45,000 procedures, with no increase in the risk of mortality for most cardiac procedures performed during the pandemic. Thus, the decline in surgical procedures during the pandemic significantly impacted the market growth.
The growing burden of vascular diseases and the rising geriatric population are the key factors in the vascular screening devices market. As per the 2020 updates by the World Health Organization (WHO), ischemic heart disease was responsible for 16% of the world’s total deaths. As per the article published in May 2021 in the Journal of Circulation Research, there were around 6,859,623 heart failure patients in the United States in 2020, reflecting 2.1% of the population. Furthermore, in 2020, the prevalence of heart failure in the United States and Canada was 1.5% and 1.9%, respectively. Thus, the growing burden of cardiovascular diseases is expected to boost market growth during the forecast period.
Furthermore, chronic diseases are more prevalent in the geriatric population and will likely boost market growth over the forecast period. For instance, the WHO’s data published in October 2021 reported that the pace of population aging is much faster than in the past, and by 2030, 1 in 6 people worldwide will be aged 60 years or over. At this time, the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion by 2030. This growth in the aging population will ultimately drive the demand for the vascular screening device market, as vascular diseases are more prone in the geriatric population.
However, reimbursement issues may restrain market growth over the forecast period.
Vascular Screening Market Trends
Hospital Segment is Expected to Hold a Major Market Share in the Vascular Screening Devices Market
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
- North America is expected to hold a significant market share in the global vascular screening devices market due to increased vascular diseases, such as coronary artery disease, renal artery diseases, and carotid artery aneurysms. Coronary artery disease is the most affected heart disease.
- According to the Centers for Disease Control and Prevention (CDC) data published in September 2020, heart disease is the leading cause of death in the United States. The same source also reported that about 805,000 Americans have a heart attack every year. As the number of deaths due to heart diseases is increasing, there is a continuous need for the proper treatment of cardiac diseases since vascular screening devices help diagnose artery blockages and narrowing and are expected to show significant growth over the forecast period.
- Moreover, the growing number of vascular ambulatory services centers in the country is expected to increase the demand for vascular screening devices, thereby boosting the market’s growth. For instance, in April 2021, a super-hybrid ambulatory surgical center was opened in Southern California, which offers the most comprehensive outpatient vascular surgical services within Orange County and represents a transformative vision for the future of ambulatory surgery.
- Thus, all the above-mentioned factors are expected to boost the market in the North American region over the forecast period.
Vascular Screening Market Competitor Analysis
The vascular screening devices market is moderately competitive and consists of several major players. Some of the companies that are operating in the vascular screening devices market are Fukuda, Unetixs Vascular Inc., Collaborative Care Diagnostics LLC (Biomedix), CorVascular Diagnostics LLC, Koven Technology Inc., D.E. Hokanson Inc., enverdis GmbH, OMRON HEALTHCARE Co. Ltd, Viasonix, and Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Vascular Diseases
4.2.2 Increasing Aging Population
4.3 Market Restraints
4.3.1 Reimbursement Issues
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Product Type
5.1.1 Portable
5.1.2 Standalone
5.2 By End User
5.2.1 Hospitals
5.2.2 Diagnostic Centres/Clinics
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Rest of the World
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Collaborative Care Diagnostics LLC (Biomedix)
6.1.2 CorVascular Diagnostics, LLC
6.1.3 D.E. Hokanson Inc.
6.1.4 enverdis GmbH
6.1.5 Fukuda
6.1.6 Koven Technology Inc.
6.1.7 OMRON HEALTHCARE Co. Ltd
6.1.8 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
6.1.9 Unetixs Vascular Inc.
6.1.10 Viasonix
6.1.11 Advin Healthcare
6.1.12 SMT Medical Technology GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS